Drug induced QT prolongation and torsades de pointes
- PMID: 14594906
- PMCID: PMC1767957
- DOI: 10.1136/heart.89.11.1363
Drug induced QT prolongation and torsades de pointes
Figures
Similar articles
-
Pharmacologic agents associated with QT interval prolongation.J Fam Pract. 2005 Jun;Suppl:S8-S14. J Fam Pract. 2005. PMID: 15938993 Review.
-
Risk of torsades de pointes with non-cardiac drugs. Doctors need to be aware that many drugs can cause qt prolongation.BMJ. 2000 Apr 29;320(7243):1158-9. doi: 10.1136/bmj.320.7243.1158. BMJ. 2000. PMID: 10784527 Free PMC article. No abstract available.
-
Drug-induced QT prolongation and sudden death.Mo Med. 2010 Jan-Feb;107(1):53-8. Mo Med. 2010. PMID: 20222297 Free PMC article. Review.
-
Drug-induced torsades de pointes in one patient with congenital long QT syndrome.Int J Cardiol. 1996 Apr 19;54(1):85-8. doi: 10.1016/0167-5273(96)02582-x. Int J Cardiol. 1996. PMID: 8792191
-
Drug-induced QT prolongation.Isr Med Assoc J. 2000 Dec;2(12):924-8. Isr Med Assoc J. 2000. PMID: 11344777 Review. No abstract available.
Cited by
-
Long-Term Antifungal Treatment in a Patient With Confirmed Allergic Bronchopulmonary Aspergillosis.Cureus. 2024 Oct 22;16(10):e72142. doi: 10.7759/cureus.72142. eCollection 2024 Oct. Cureus. 2024. PMID: 39575033 Free PMC article.
-
Concentration-QTcF analysis of quizartinib in patients with newly diagnosed FLT3-internal-tandem-duplication-positive acute myeloid leukemia.Clin Transl Sci. 2024 Nov;17(11):e70065. doi: 10.1111/cts.70065. Clin Transl Sci. 2024. PMID: 39533519 Free PMC article. Clinical Trial.
-
Assessing the Risk of QT Prolongation in a Psychiatric Inpatient Cohort: A Retrospective Cross-Sectional Study.Pharmaceuticals (Basel). 2024 Oct 16;17(10):1373. doi: 10.3390/ph17101373. Pharmaceuticals (Basel). 2024. PMID: 39459013 Free PMC article.
-
The Best ECG Lead for Predicting the Risk of Drug-Induced Torsade De Pointes Using Corrected QT Interval: A Comparative Prognostic Study.Arch Acad Emerg Med. 2024 Sep 8;13(1):e5. doi: 10.22037/aaem.v12i1.2323. eCollection 2025. Arch Acad Emerg Med. 2024. PMID: 39318863 Free PMC article.
-
Fexinidazole optimization: enhancing anti-leishmanial profile, metabolic stability and hERG safety.RSC Med Chem. 2024 Aug 30;15(11):3837-52. doi: 10.1039/d4md00426d. Online ahead of print. RSC Med Chem. 2024. PMID: 39297060
References
-
- De Ponti F, Poluzzi E, Montanaro N, et al. QTc and psychotropic drugs. Lancet 2000;356:75–6. - PubMed
-
- Wysowski DK, Bacsanyi J. Cisapride and fatal arrhythmia. N Engl J Med 1996;335:290–1. - PubMed
-
- Dapro B. Spectrum of drugs prolonging QT interval and the incidence of torsades de pointes. Eur Heart J 2001;3(suppl K):K70–80. ▸ A good review providing an insight into the incidence of drug induced TdP.
-
- Antzelevitch C, Sicouri S. Clinical relevance of cardiac arrhythmias generated by afterdepolarisation: role of M cells in the generation of U wave, triggered activity, and torsades de pointes. J Am Coll Cardiol 1994;23:259–77. ▸ An important study that demonstrated the cellular mechanism of drug induced QT prolongation and TdP. - PubMed
-
- Roden DM. Torsades de pointes. Clin Cardiol 1993;16:683–6. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources